Orion Pharma Limited
Orion Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 1965, the company has achieved notable milestones, including the development of a diverse portfolio of high-quality generic and branded medications. Specialising in therapeutic areas such as cardiology, diabetes, and infectious diseases, Orion Pharma is recognised for its commitment to innovation and quality. Its core products, which include a range of prescription medications and over-the-counter solutions, are distinguished by their efficacy and affordability. With a strong market position, Orion Pharma Limited has garnered accolades for its contributions to healthcare, making it a trusted name in the pharmaceutical sector. The company continues to focus on expanding its reach and enhancing its product offerings to meet the evolving needs of patients and healthcare providers.
DitchCarbon Score
How does Orion Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orion Pharma Limited's score of 22 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Orion Pharma Limited's reported carbon emissions
Orion Pharma Limited, headquartered in Bangladesh (BD), currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current impact on climate change or their progress towards sustainability. However, the absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises environmental responsibility, it is essential for Orion Pharma to establish clear climate commitments and measurable targets to align with global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orion Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
